samzenpus from the turning-on-the-autodoc dept.
eldavojohn writes "In the grand scheme of things, antibiotics are a very temporary solution to aid humans in combating bacteria. Bacterial resistance to said antibiotics is an increasing fear and DARPA's 'Rapidly Adaptable Nanotherapeutics' solicitation reveals they're interested in a more permanent solution as modifying the genes of harmless bacteria can result in powerful bioweapons. Like siRNA, DARPA is hoping for more nanomolecules that can specifically target cells and deliver medicine to them anywhere in the body. Most amazing about this proposal is that it's aimed at small businesses and hopes to turn a process that takes decades to study a new antibiotic into a few weeks to manufacture nanomedicine to specifically target bacteria."
Those who can, do; those who can't, write.
Those who can't write work for the Bell Labs Record.